L
Lyra Therapeutics D
D
LYRA
10.385
USD
-1.05
(-9.14%)
مغلق
حجم التداول
0
الربح لكل سهم
-27
العائد الربحي
-
P/E
-0
حجم السوق
13,763,697
العنوان: Lyra Therapeutics Inc
القطاع: Healthcare
الصناعة: Biotechnology
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.